Your browser doesn't support javascript.
loading
Mitigating the Immunogenicity of AAV-Mediated Gene Therapy with an Immunosuppressive Phosphoserine-Containing Zwitterionic Peptide.
Yuan, Zhefan; Li, Bowen; Gu, Wenchao; Luozhong, Sijin; Li, Ruoxin; Jiang, Shaoyi.
Afiliação
  • Yuan Z; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
  • Li B; Department of Chemical Engineering, University of Washington, Seattle, Washington 98195, United States.
  • Gu W; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
  • Luozhong S; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
  • Li R; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
  • Jiang S; Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York 14853, United States.
J Am Chem Soc ; 144(44): 20507-20513, 2022 11 09.
Article em En | MEDLINE | ID: mdl-36301739

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Dependovirus Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Dependovirus Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article